Cold & Cough Remedies - Norway

  • Norway
  • In 2024, the revenue in the Cold & Cough Remedies market market in Norway amounts to US$27.76m.
  • It is projected that the market will experience an annual growth rate of 2.79% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, with US$11,190.00m in 2024.
  • Considering the total population, per person revenues of US$5.03 are generated in Norway in 2024.
  • The demand for natural and herbal cold & cough remedies is on the rise in Norway, as consumers prioritize holistic and sustainable healthcare solutions.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Norway has been experiencing steady growth in recent years, driven by customer preferences for natural and organic products, as well as increasing awareness about the importance of maintaining a healthy immune system.

Customer preferences:
In Norway, there is a growing demand for natural and organic cold and cough remedies. Consumers are becoming more conscious about the ingredients used in these products and are actively seeking out options that are free from artificial additives and chemicals. This shift in consumer preferences is driven by a desire for healthier and more sustainable options, as well as a general trend towards clean and natural living.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Norway is the rising popularity of herbal remedies. Traditional herbal medicines, such as Echinacea and elderberry, are known for their immune-boosting properties and have gained significant traction among consumers. Additionally, there is a growing interest in natural remedies that are backed by scientific research, such as vitamin C and zinc supplements.Another trend in the market is the increasing availability of over-the-counter (OTC) cold and cough remedies. Pharmacies and convenience stores are expanding their range of OTC products, making it easier for consumers to access these remedies without a prescription. This convenience factor has contributed to the overall growth of the market.

Local special circumstances:
Norway's cold and harsh climate contributes to a higher prevalence of cold and coughs among the population. The long winters and low temperatures make people more susceptible to respiratory illnesses, leading to a higher demand for cold and cough remedies. This local special circumstance creates a favorable environment for the growth of the market.

Underlying macroeconomic factors:
Norway has a strong economy with high disposable income levels. This allows consumers to prioritize their health and wellness, including investing in cold and cough remedies. Additionally, the country has a well-developed healthcare system that emphasizes preventive care, which further drives the demand for these products.In conclusion, the Cold & Cough Remedies market in Norway is growing due to customer preferences for natural and organic products, the popularity of herbal remedies, the increasing availability of OTC products, the local special circumstance of a cold climate, and the underlying macroeconomic factors of a strong economy and emphasis on preventive healthcare.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)